Reuters logo
CORRECTED-Valeant profit slides, narrows 4th-qtr cash EPS forecast
November 2, 2012 / 10:21 AM / 5 years ago

CORRECTED-Valeant profit slides, narrows 4th-qtr cash EPS forecast

(Corrects headline and paragraph 1 to say the company narrowed its cash EPS forecast, it did not cut its profit forecast for the fourth quarter)

Nov 2 (Reuters) - Valeant Pharmaceuticals International Inc , Canada’s biggest public drugmaker, reported an 81 percent drop in third-quarter profit, and the company narrowed its forecast for cash earnings per share for the current quarter.

Net income fell to $7.6 million, or 2 cents per share, from $40.9 million, or 13 cents per share, a year earlier.

Total revenue rose 47 percent to $884.1 million. (Reporting by Bhaswati Mukhopadhyay in Bangalore and Allison Martell in Toronto; Editing by Sriraj Kalluvila)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below